Determinants of primaquine and carboxyprimaquine exposures in children and adults with plasmodium vivax malaria

by Cindy S. Chu, James A. Watson, Aung Pyae Phyo, Htun Htun Win, Widi Yotyingaphiram, Suradet Thinraow, Nay Lin Soe, Aye Aye Aung, Pornpimon Wilaisrisak, Kanokpich Kraft, Mallika Imwong, Warunee Hanpithakpong, Daniel Blessborn, Joel Tarning, Stéphane Proux, Clare Ling, François H. Nosten, Nicholas J. White
Published 2022

Single low dose primaquine (0.25mg/kg) does not cause clinically significant haemolysis in G6PD deficient subjects

by Germana Bancone, Nongnud Chowwiwat, Raweewan Somsakchaicharoen, Lalita Poodpanya, Paw Khu Moo, Gornpan Gornsawun, Ladda Kajeechiwa, May Myo Thwin, Santisuk Rakthinthong, Suphak Nosten, Suradet Thinraow, Slight Naw Nyo, Clare L. Ling, Jacher Wiladphaingern, Naw Lily Kiricharoen, Kerryn A. Moore, Nicholas J. White, Francois Nosten
Published 2018

Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in plasmodium vivax malaria

by Cindy S. Chu, Aung Pyae Phyo, Claudia Turner, Htun Htun Win, Naw Pet Poe, Widi Yotyingaphiram, Suradet Thinraow, Pornpimon Wilairisak, Rattanaporn Raksapraidee, Verena I. Carrara, Moo Kho Paw, Jacher Wiladphaingern, Stéphane Proux, Germana Bancone, Kanlaya Sriprawat, Sue J. Lee, Atthanee Jeeyapant, James Watson, Joel Tarning, Mallika Imwong, François Nosten, Nicholas J. White
Published 2020